NM_001394073.1:c.975A>C

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_StrongBP7

The NM_001394073.1(HS6ST2):​c.975A>C​(p.Ala325Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000937 in 1,067,039 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. A325A) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 9.4e-7 ( 0 hom. 0 hem. )

Consequence

HS6ST2
NM_001394073.1 synonymous

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.209

Publications

0 publications found
Variant links:
Genes affected
HS6ST2 (HGNC:19133): (heparan sulfate 6-O-sulfotransferase 2) Heparan sulfate proteoglycans are ubiquitous components of the cell surface, extracellular matrix, and basement membranes, and interact with various ligands to influence cell growth, differentiation, adhesion, and migration. This gene encodes a member of the heparan sulfate (HS) sulfotransferase gene family, which catalyze the transfer of sulfate to HS. Different family members and isoforms are thought to synthesize heparan sulfates with tissue-specific structures and functions. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
HS6ST2 Gene-Disease associations (from GenCC):
  • Paganini-Miozzo syndrome
    Inheritance: Unknown, XL Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP7
Synonymous conserved (PhyloP=-0.209 with no splicing effect.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HS6ST2NM_001394073.1 linkc.975A>C p.Ala325Ala synonymous_variant Exon 3 of 5 ENST00000370833.7 NP_001381002.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HS6ST2ENST00000370833.7 linkc.975A>C p.Ala325Ala synonymous_variant Exon 3 of 5 5 NM_001394073.1 ENSP00000359870.3 Q96MM7-4

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD4 exome
AF:
9.37e-7
AC:
1
AN:
1067039
Hom.:
0
Cov.:
26
AF XY:
0.00
AC XY:
0
AN XY:
342045
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25613
American (AMR)
AF:
0.00
AC:
0
AN:
31575
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18715
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29086
South Asian (SAS)
AF:
0.00
AC:
0
AN:
49443
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39109
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4024
European-Non Finnish (NFE)
AF:
0.00000121
AC:
1
AN:
824614
Other (OTH)
AF:
0.00
AC:
0
AN:
44860
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
22

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
7.8
DANN
Benign
0.73
PhyloP100
-0.21

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143752287; hg19: chrX-131842495; API